Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BTTX - Better Therapeutics, Inc.

Previous close
0.05
0.050   100.000%

Share volume: 0
Last Updated: Fri 15 Mar 2024 08:27:51 PM CET
Data Processing, Hosting, and Related Services: 27.27%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-98.67%
1 Year
-99.94%
2 Year
-99.99%
Key data
Stock price
$0.05
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.27
52 WEEK CHANGE
-$99.94
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
49.862 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Frank L. Karbe
Region: US
Website: bettertx.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. Its lead product candidate in development is BT-001, a platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure.

Recent news